ArticleJournal of cheminformatics2026
Sampling out-of-distribution chemical spaces via Bayesian flow.
Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Generating novel molecules with higher properties than the training space, namely the out-of-distribution generation, is important for de novo drug design. However, it is not easy for distribution learning-based models, for example diffusion models, to solve this challenge as these methods are designed to fit the distribution of training data as close as possible. In this paper, we show that Bayesian flow network, especially ChemBFN model, is capable of intrinsically generating high quality out-of-distribution samples that meet several scenarios. A reinforcement learning strategy is added to the ChemBFN and a controllable ordinary differential equation solver-like generating process is employed that accelerate the sampling processes. Most importantly, we introduce a semi-autoregressive strategy during training and inference that enhances the model performance and surpass the state-of-the-art models. A theoretical analysis of out-of-distribution generation in ChemBFN with semi-autoregressive approach is included as well.Scientific contributionBenchmarked on both small molecule and protein generative tasks, ChemBFN method showed outstanding out-of-distribution performance without complex modification, proving its feasibility of exploring chemical spaces outside the training data and its value as a tool to accelerate drug design and materials discovery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.